FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1512547215> ?p ?o ?g. }

• W1512547215 abstract "This study was designed to evaluate the utility of transdermal fentanyl (TDF, Durogesic®) for the treatment of pain due to osteoarthritis (OA) of the knee or hip, which was not adequately controlled by non-opioid analgesics or weak opioids. The second part of the trial, investigating TDF in patients with rheumatoid arthritis (RA) is reported separately. Current analgesia was optimised during a 1-week run-in. Patients then received 28 days treatment with TDF starting at 25 μg/hr, with the option to increase the dose until adequate pain control was achieved. Metoclopramide was taken during the first week and then as needed. Of the 159 patients recruited, 75 with OA knee and 44 with OA hip completed the treatment phase, 30 knee and 18 hip patients entered the one-week taper-off phase. The most frequently used maximum dose of TDF was 25 μg/hr. The number of patients with adequate pain control increased during the run-in period from 4% to 27%, and further increased during TDF treatment to 88% on day 28. From baseline to endpoint, there were significant reductions in pain (p < 0.001) and improvements in functioning (p < 0.001) and physical (p < 0.001) and mental (p < 0.05) health. Scores for 'pain right now' decreased significantly within 24 hours of starting TDF treatment. TDF was assessed favourably and 84% of patients would recommend it for OA-related pain. Nausea and vomiting were the most common adverse events (reported by 32% and 26% of patients respectively), despite prophylaxis with metoclopramide, which showed limited efficacy in this setting. TDF significantly increased pain control, and improved functioning and quality of life. Metoclopramide appeared to be of limited value in preventing nausea and vomiting; more effective anti-emetic treatment may enable more people to benefit from strong opioids such as TDF. This study suggests that four weeks is a reasonable period to test the benefit of adding TDF to improve pain control in OA patients and that discontinuing therapy in cases of limited benefit creates no major obstacles." @default.
• W1512547215 created "2016-06-24" @default.
• W1512547215 creator A5021030323 @default.
• W1512547215 creator A5057763735 @default.
• W1512547215 creator A5089477356 @default.
• W1512547215 date "2005-06-15" @default.
• W1512547215 modified "2023-10-13" @default.
• W1512547215 title "Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre study" @default.
• W1512547215 cites W127956218 @default.
• W1512547215 cites W157777597 @default.
• W1512547215 cites W1766118422 @default.
• W1512547215 cites W1951915552 @default.
• W1512547215 cites W1979327994 @default.
• W1512547215 cites W1986296414 @default.
• W1512547215 cites W1987770280 @default.
• W1512547215 cites W1989946643 @default.
• W1512547215 cites W2000748607 @default.
• W1512547215 cites W2004705088 @default.
• W1512547215 cites W2032231612 @default.
• W1512547215 cites W2035397928 @default.
• W1512547215 cites W2036407861 @default.
• W1512547215 cites W2037377025 @default.
• W1512547215 cites W2039443925 @default.
• W1512547215 cites W2047560765 @default.
• W1512547215 cites W2048508229 @default.
• W1512547215 cites W2059867560 @default.
• W1512547215 cites W2062755530 @default.
• W1512547215 cites W2072893909 @default.
• W1512547215 cites W2090221910 @default.
• W1512547215 cites W2117950925 @default.
• W1512547215 cites W2157882966 @default.
• W1512547215 cites W2162840262 @default.
• W1512547215 cites W2274722622 @default.
• W1512547215 cites W2290133626 @default.
• W1512547215 cites W2320909684 @default.
• W1512547215 cites W2463943666 @default.
• W1512547215 cites W2610860323 @default.
• W1512547215 cites W4238510509 @default.
• W1512547215 cites W4292806894 @default.
• W1512547215 cites W4300668950 @default.
• W1512547215 cites W89131215 @default.
• W1512547215 doi "https://doi.org/10.1186/1471-2474-6-31" @default.
• W1512547215 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1181817" @default.
• W1512547215 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15958159" @default.
• W1512547215 hasPublicationYear "2005" @default.
• W1512547215 type Work @default.
• W1512547215 sameAs 1512547215 @default.
• W1512547215 citedByCount "22" @default.
• W1512547215 countsByYear W15125472152012 @default.
• W1512547215 countsByYear W15125472152013 @default.
• W1512547215 countsByYear W15125472152016 @default.
• W1512547215 countsByYear W15125472152021 @default.
• W1512547215 countsByYear W15125472152023 @default.
• W1512547215 crossrefType "journal-article" @default.
• W1512547215 hasAuthorship W1512547215A5021030323 @default.
• W1512547215 hasAuthorship W1512547215A5057763735 @default.
• W1512547215 hasAuthorship W1512547215A5089477356 @default.
• W1512547215 hasBestOaLocation W15125472151 @default.
• W1512547215 hasConcept C126322002 @default.
• W1512547215 hasConcept C142724271 @default.
• W1512547215 hasConcept C170493617 @default.
• W1512547215 hasConcept C197934379 @default.
• W1512547215 hasConcept C204787440 @default.
• W1512547215 hasConcept C205679159 @default.
• W1512547215 hasConcept C2776164576 @default.
• W1512547215 hasConcept C2778479196 @default.
• W1512547215 hasConcept C2780580376 @default.
• W1512547215 hasConcept C2780852908 @default.
• W1512547215 hasConcept C2781063702 @default.
• W1512547215 hasConcept C2781072394 @default.
• W1512547215 hasConcept C42219234 @default.
• W1512547215 hasConcept C71924100 @default.
• W1512547215 hasConcept C98274493 @default.
• W1512547215 hasConceptScore W1512547215C126322002 @default.
• W1512547215 hasConceptScore W1512547215C142724271 @default.
• W1512547215 hasConceptScore W1512547215C170493617 @default.
• W1512547215 hasConceptScore W1512547215C197934379 @default.
• W1512547215 hasConceptScore W1512547215C204787440 @default.
• W1512547215 hasConceptScore W1512547215C205679159 @default.
• W1512547215 hasConceptScore W1512547215C2776164576 @default.
• W1512547215 hasConceptScore W1512547215C2778479196 @default.
• W1512547215 hasConceptScore W1512547215C2780580376 @default.
• W1512547215 hasConceptScore W1512547215C2780852908 @default.
• W1512547215 hasConceptScore W1512547215C2781063702 @default.
• W1512547215 hasConceptScore W1512547215C2781072394 @default.
• W1512547215 hasConceptScore W1512547215C42219234 @default.
• W1512547215 hasConceptScore W1512547215C71924100 @default.
• W1512547215 hasConceptScore W1512547215C98274493 @default.
• W1512547215 hasIssue "1" @default.
• W1512547215 hasLocation W15125472151 @default.
• W1512547215 hasLocation W15125472152 @default.
• W1512547215 hasLocation W15125472153 @default.
• W1512547215 hasLocation W15125472154 @default.
• W1512547215 hasOpenAccess W1512547215 @default.
• W1512547215 hasPrimaryLocation W15125472151 @default.
• W1512547215 hasRelatedWork W1970037881 @default.
• W1512547215 hasRelatedWork W1979523195 @default.
• W1512547215 hasRelatedWork W1981226422 @default.
• W1512547215 hasRelatedWork W2001672425 @default.
• W1512547215 hasRelatedWork W2062903148 @default.

• next